Lv2
125 积分 2022-06-08 加入
Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial
3天前
已完结
Sacituzumab tirumotecan versus docetaxel for previously treated EGFR -mutated advanced non-small cell lung cancer: multicentre, open label, randomised controlled trial
3个月前
已完结
Non-small cell lung cancer in young adults: presentation and survival in the English National Lung Cancer Audit
3个月前
已完结
Small Cell Lung Cancer
3个月前
已完结
Two cases of endobronchial aspergilloma complicated with primary and metastatic lung cancer: A case report and literature review
8个月前
已完结
Endobronchial aspergilloma—a comprehensive literature review with focus on diagnosis and treatment modalities
8个月前
已完结
Multidisciplinary expert consensus on diagnosis and treatment of multiple lung cancers
10个月前
已完结
Immune checkpoint inhibitors for advanced non-small cell lung cancer with preexisting COPD and CT-defined emphysema: A systematic review and meta-analysis
11个月前
已关闭
Moving towards personalized treatments of immune-related adverse events
11个月前
已完结
High-dose Furmonertinib in patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastases: A prospective real-world study
1年前
已完结
皖公网安备34019202002308
